Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1818506
Max Phase: Preclinical
Molecular Formula: C28H22F2N4O5
Molecular Weight: 532.50
Molecule Type: Small molecule
Associated Items:
ID: ALA1818506
Max Phase: Preclinical
Molecular Formula: C28H22F2N4O5
Molecular Weight: 532.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(/C=C2\N=C(c3ccccc3)OC2=O)cc1OCC(O)(Cn1cncn1)c1ccc(F)cc1F
Standard InChI: InChI=1S/C28H22F2N4O5/c1-37-24-10-7-18(11-23-27(35)39-26(33-23)19-5-3-2-4-6-19)12-25(24)38-15-28(36,14-34-17-31-16-32-34)21-9-8-20(29)13-22(21)30/h2-13,16-17,36H,14-15H2,1H3/b23-11-
Standard InChI Key: PYGQPKVZTFBEFL-KSEXSDGBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 532.50 | Molecular Weight (Monoisotopic): 532.1558 | AlogP: 3.88 | #Rotatable Bonds: 9 |
Polar Surface Area: 108.06 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 12.44 | CX Basic pKa: 2.00 | CX LogP: 4.37 | CX LogD: 4.37 |
Aromatic Rings: 4 | Heavy Atoms: 39 | QED Weighted: 0.26 | Np Likeness Score: -1.03 |
1. Borate HB, Sawargave SP, Chavan SP, Chandavarkar MA, Iyer R, Tawte A, Rao D, Deore JV, Kudale AS, Mahajan PS, Kangire GS.. (2011) Novel hybrids of fluconazole and furanones: design, synthesis and antifungal activity., 21 (16): [PMID:21757344] [10.1016/j.bmcl.2011.06.022] |
Source(1):